| EPA0077 | Upregulation of TCF1 improves the efficiency of latency reversing agents for HIV-1 transcriptional reactivation | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0076 | Tat diversity in intact versus defective proviral HIV-1 DNA genomes across viral subtypes | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0075 | Synergistic effects of romidepsin with PI3K inhibitors in reducing the pool of HIV latently infected cells ex vivo | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0074 | Assessment of monovalent and bivalent SMAC mimetics to both shock and kill the HIV reservoir | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0073 | Developing triplex forming oligonucleotides as a ‘block and lock’ strategy for an HIV cure | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0072 | Characterisation of HIV latency and reactivation in human macrophages | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0071 | NK cell-mediated viral control of SIV in sooty mangabey lymph nodes | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0070 | Myeloid production of GDF15 influences HIV reservoir size in ART-treated people living with HIV | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0069 | A case of persistent low-level viremia during ART fueled by a clonally expanded provirus with a 3 base deletion in HIV's major splice donor site | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0068 | Long-term protection against HIV infection after discontinuation treatment with ponatinib for 1 year | E-poster | Understanding and targeting persistent HIV reservoirs |